Live
FierceBiotechDespite data concerns, Roche’s oral SERD can still be largest product in company history: execFierceBiotechRegeneron ushers in new genetic medicine era with groundbreaking gene therapy approvalThermo FisherThermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business JournalsAgilentEarnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - TradingViewFierceBiotechKurma closes €215M Europe-focused fund to spread across 20 biotechsFierceBiotechPfizer cans work on next-gen conjugate in cancer patientsBioWorldAnglonordic panelists discuss how to get the most from AIThermo FisherThermo Fisher falls after earnings top estimates, but growth concerns persist - Yahoo FinanceThermo FisherThermo Fisher (TMO) Q1 2026 Earnings Transcript - The Motley FoolLonza NewsBanks kick off talks on Lone Star’s $1.75 billion Lonza unit debt - Bloomberg News - TradingViewPLoS BiologySea urchin eggs contain a plastid-derived structure that contributes to their development
FierceBiotech Dec 12, 2025

Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’

Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’

Original
Body unavailable. Use the original source.